Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2:: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists

被引:138
|
作者
Shinomiya, S
Naraba, H
Ueno, A
Utsunomiya, I
Maruyama, T
Ohuchida, S
Ushikubi, F
Yuki, K
Narumiya, S
Sugimoto, Y
Ichikawa, A
Oh-ishi, S
机构
[1] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Dept Pharmacol, Minato Ku, Tokyo 1088641, Japan
[3] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan
[4] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[5] Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan
[6] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan
[7] Kitasato Inst, Minato Ku, Tokyo 1088642, Japan
关键词
LP receptor; EP2; receptor; EP4; TNF alpha; IL-10; zymosan;
D O I
10.1016/S0006-2952(01)00586-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To know which receptors of prostaglandins are involved in the regulation of TNF alpha and interleukin 10 (IL-10) production, we examined the production of these cytokines in murine peritoneal macrophages stimulated with zymosan. The presence of PGE, or the PGI, analog carbacyclin in the medium reduced the TNF alpha production to one-half, whereas IL-10 production increased several fold; and indomethacin caused the reverse effects, suggesting that endogenous prostaglandins may have a regulatory effect on the cytokine production. Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNF alpha production, but up-regulation on the IL-IO production; while EP1 and EP3 agonists showed no effect. Macrophages harvested from prostaglandin I (IP) receptor-deficient mice showed the up- and down-regulatory effects on the cytokine production by the EP2 and EP4 agonists or PGE(2), but no effect was obtained by carbacyclin. On the contrary, macrophages from EP2-deficient mice showed the effect by PGE(2), carbacyclin, and the EP4 agonist, but not by the EP2 agonist; and the cells from EP4-deficient mice showed the effect by PGE,, carbacyclin, and EP2 agonist, but not by the EP3 agonist. These functional effects of prostaglandins well accorded with the mRNA expression of TNF alpha and IL-10 when such expression was examined by the RT-PCR method. The peritoneal macrophages from normal mice expressed IF, EP2, and EP4 receptors, but not EPI and EP3, when examined by RT-PCR. Thus the results suggest that PGI, and PGE, generated simultaneously with cytokines by macrophages treated with zymosan may influence the cytokine production through IF, EP2, and EP4 receptors. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1153 / 1160
页数:8
相关论文
共 50 条
  • [21] Effects of a novel selective prostaglandin E2 receptor subtype EP4 agonist on inflammatory reaction and hyperalgesia in monoarthritis
    Omote, K
    Kawamata, T
    Kawamata, M
    Nakayama, Y
    Namiki, A
    ANESTHESIOLOGY, 2000, 93 (3A) : U202 - U202
  • [22] Prostaglandin E2 receptor selective agonists E-prostanoid 2 and E-prostanoid 4 may have therapeutic effects on ovalbumin-induced bronchoconstriction
    Tanaka, H
    Kanako, S
    Abe, S
    CHEST, 2005, 128 (05) : 3717 - 3723
  • [23] Discovery and bone anabolic activity of highly selective EP4 receptor prostaglandin E2 (PGE2) agonists.
    Cameron, KO
    Lefker, BA
    Crawford, DT
    DaSilvaJardine, P
    DeNinno, SL
    Gilbert, S
    Grasser, WA
    Ke, HZ
    Lu, BH
    Owen, TA
    Paralkar, VM
    Qi, H
    Scott, DO
    Thompson, DD
    Tjoa, CM
    Zawistoski, MP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U60 - U60
  • [24] Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure
    Vukicevic, S.
    Simic, P.
    Borovecki, F.
    Grgurevic, L.
    Rogic, D.
    Orlic, I.
    Grasser, W. A.
    Thompson, D. D.
    Paralkar, V. M.
    KIDNEY INTERNATIONAL, 2006, 70 (06) : 1099 - 1106
  • [25] Effect of intestinal microflora on the production of interleukin 10 and prostaglandin E2 in serum and Kupffer cells from germfree and conventional mice
    Ikeda, Masamichi
    Ohira, Hideo
    Toyama, Yukiko
    Katagiri, Tikae
    Sakakibara, Bunsaku
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2007, 41 (03) : 169 - 174
  • [26] Effects of prostaglandin E2 (PGE2) and selective prostaglandin E receptor (EP) agonists on 3′,5′ cyclic adenosine monophosphate (cAMP) production in osteoblastic cells from wild type and EP2 or EP4 knockout mice.
    Sakuma, Y
    Pilbeam, CC
    Pan, LC
    Raisz, LG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S441 - S441
  • [27] Lipopolysaccharide toxicity to hippocampal intermediate neuronal progenitors is diminished in mice lacking prostaglandin E2 receptor subtype EP1
    Keene, C. Dirk
    Chang, Rubens
    Hevner, Robert F.
    Montine, Thomas J.
    FASEB JOURNAL, 2008, 22
  • [28] Deficiency of Prostaglandin E2 Receptor Subtype 4 Exacerbates Left Ventricular Remodeling and Myocardial Fibrosis in Diet-induced Mice
    Ying, Fan Sara
    Cai, Yin David
    Tang, Hoi Ching Eva
    Xia, Zhengyuan
    FASEB JOURNAL, 2018, 32 (01):
  • [29] Mice lacking the prostaglandin E2 EP1 receptor subtype have hypotension hyperrenimia and altered responses to angiotensin II
    Audoly, LP
    Kim, H
    Flannery, PJ
    Stock, JL
    McNeish, JD
    Coffman, TM
    FASEB JOURNAL, 1999, 13 (07): : A1549 - A1549
  • [30] Lipopolysaccharide toxicity to hippocampal intermediate neuronal progenitors is diminished in mice lacking prostaglandin E2 receptor subtype EP1
    Keene, C. Dirk
    Chang, Rubens
    Hevner, Robert F.
    Montine, Thomas J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 512 - 512